CMS Accepts Myomo’s Application to Classify the MyoPro as a Brace
MyoPro expected to be reimbursed by CMS in a lump-sum payment rather than as a rental should the proposal be finalized following a 60-day public comment period

BOSTON—Myomo, Inc. (NYSE American: MYO), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that its request to the Centers for Medicare and Medicaid Services (CMS) to classify the company’s MyoPro as a brace has been published for public comment.

AppliedVR Becomes First VR Provider to Receive HCPCS Level II Code from CMS as DME
Decision places AppliedVR's flagship product RelieVR in an existing benefit category, providing a next step for securing public and commercial health insurance coverage.

LOS ANGELES— AppliedVR, an immersive therapeutics (ITx) company, announced the Centers for Medicare and Medicaid Services (CMS) established a unique Healthcare Common Procedure Coding System (HCPCS) Level II code (E1905) for its flagship product, the RelieVRx program.

RAC to Audit Glucose Test Strips

WASHINGTON, D.C. (June 18, 2019)—Performant, the Recovery Audit Contractor (RAC), has received approval to audit blood glucose test or reagent strips (A4253) as of June 14, 2019. This is a national complex review and the description of the review states: “The quantity of glucose test strips (A4353) that are covered depends upon the usual medical needs of the diabetic patient.

Medtrade 2014: Winning Strategies for Consumer Power

ATLANTA —Times are tough right now for power-mobility providers with burdensome audits and low reimbursement rates. Improper alignment of product-to-patient, and branding as a "one size fits all" company are part of the problem.

Now more than ever, it is important for providers to brand their company as one that can match the right product to the right patient. Companies that match to patients’ needs will gain a disproportionate share of business.